CymaBay Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Private Companies | 10,517 | 0.00886% |
| Individual Insiders | 723,401 | 0.61% |
| VC/PE Firms | 6,940,000 | 5.85% |
| Hedge Funds | 11,111,111 | 9.36% |
| Institutions | 99,866,270 | 84.2% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 35.6%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 11,111,111 | US$360.8m | 7.87% | 4.67% | |||
| 9,610,239 | US$312.0m | 23.3% | 0.01% | |||
| 6,940,000 | US$225.3m | 0% | 3.06% | |||
| 6,306,149 | US$204.8m | 9.72% | no data | |||
| 6,103,797 | US$198.2m | -10.3% | 0.08% | |||
| 4,465,161 | US$145.0m | 135% | 0.01% | |||
| 4,024,400 | US$130.7m | -0.46% | 2.7% | |||
| 3,992,711 | US$129.6m | 12.3% | 0.08% | |||
| 3,246,308 | US$105.4m | -0.69% | 0.04% | |||
| 3,061,887 | US$99.4m | 95.2% | 0.01% | |||
| 2,993,945 | US$97.2m | -3.97% | 0.36% | |||
| 2,797,916 | US$90.8m | 22.4% | no data | |||
| 2,673,750 | US$86.8m | -13% | 12.87% | |||
| 2,628,000 | US$85.3m | -36.3% | 0.16% | |||
| 2,573,700 | US$83.6m | 3.26% | 0.18% | |||
| 2,380,105 | US$77.3m | 14.7% | 0.01% | |||
| 1,967,858 | US$63.9m | -9.41% | 0.31% | |||
| 1,946,936 | US$63.2m | 8.55% | 1.47% | |||
| 1,800,000 | US$58.4m | -53.3% | 2.99% | |||
| 1,734,159 | US$56.3m | -2.33% | 3.18% | |||
| 1,625,000 | US$52.8m | 0% | 5.23% | |||
| 1,497,331 | US$48.6m | 0% | 6.95% | |||
| 1,411,769 | US$45.8m | 0% | 3.19% | |||
| 1,377,964 | US$44.7m | 202% | 0.02% | |||
| 1,321,219 | US$42.9m | 7,410% | 0.14% |